Potrero Medical Revenue and Competitors
Estimated Revenue & Valuation
- Potrero Medical's estimated annual revenue is currently $19.3M per year.
- Potrero Medical received $26.6M in venture funding in July 2018.
- Potrero Medical's estimated revenue per employee is $251,000
- Potrero Medical's total funding is $52.7M.
- Potrero Medical has 77 Employees.
- Potrero Medical grew their employee count by -21% last year.
Potrero Medical Competitors & AlternativesAdd Company
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is Potrero Medical?
Potrero Medical is a predictive health company that is developing the next generation of smart sensors and artificial intelligence. Currently, Potrero is focused on commercializing Accuryn® Monitoring System, a critical care monitoring system that measures urine output, core body temperature, and intra-abdominal pressure.keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals
Number of Employees
Employee Growth %
Potrero Medical News
C. R. Bard, ConvaTec Group PLC, Holtech Medical, Centurion Medical Products, Biometrix, Stryker Corporation, Spiegelberg GmbH, Nutrimedics, Potrero Medical,...
Potrero Medical, Inc. is a personalized medicine platform transforming patient care through precision fluid management and analytics that offer...
... Holtech Medical, Centurion Medical Products, Biometrix, Stryker Corporation, Spiegelberg GmbH, Nutrimedics, Potrero Medical, Gaeltec,.
Predictive health company Potrero Medical has raised $11.7 million of a proposed $15 million, according to a Securities and Exchange ...
Predictive health company Potrero Medical has raised $11.7 million of a proposed $15 million, according to a Securities and Exchange Commission filing. The Hayward, Calif.-based company’s Accuryn system is designed to use urinary catheters as diagnostic tools. The device provides real-time meas ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|
Potrero Medical Funding
|2018-07-10||$26.6M||C||GT Healthcare Capital Partners||Article|